WFC Research Update — August 28, 2026
Updated Thesis
Wells Fargo & Company is a diversified financial services firm offering banking, investment, mortgage, and consumer and commercial finance products across four segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The company has demonstrated strong recent performance with revenue growth of 11.3% and earnings growth of 16.6% in the most recent quarter, driven by robust loan and deposit growth and market share gains in investment banking. Despite this, the stock trades at a P/E of 11.44 and P/S of 1.99, with a fair value estimate of $103.68, implying 22% upside from the current price of $84.97.
The investment grade as of this refresh is B — solid business quality. B-tier business, fair valuation with 22% upside to fair value.
Key Metrics at a Glance
- Revenue growth: +11.3% year over year
- Net margin: 17.5%
- Fair value upside: +22.0% to our estimate of $104
Current price: $84.97
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Wells Fargo & Company remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full WFC research →](/stocks/WFC)